Cytomegalovirus (CMV) DNA quantification in bronchoalveolar lavage fluid of immunocompromised patients with CMV pneumonia.

about

Cytomegalovirus (CMV) DNA quantification in bronchoalveolar lavage fluid of immunocompromised patients with CMV pneumonia.

Item

http://www.wikidata.org/entity/Q47588050

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Cytomegalovirus (CMV) DNA quan ...... d patients with CMV pneumonia.

@en

type

Item

label

Cytomegalovirus (CMV) DNA quan ...... d patients with CMV pneumonia.

@en

prefLabel

Cytomegalovirus (CMV) DNA quan ...... d patients with CMV pneumonia.

@en

P1476

Cytomegalovirus (CMV) DNA quan ...... d patients with CMV pneumonia.

@en

P2093

Andrew Harold Limper

http://www.w3.org/2001/XMLSchema#string

Brian Lahr

http://www.w3.org/2001/XMLSchema#string

Jeffrey J Germer

http://www.w3.org/2001/XMLSchema#string

Joseph D C Yao

http://www.w3.org/2001/XMLSchema#string

Matthew J Binnicker

http://www.w3.org/2001/XMLSchema#string

Raymund R Razonable

http://www.w3.org/2001/XMLSchema#string

P2860

Definitions of cytomegalovirus infection and disease in transplant recipients

Molecular and Culture-Based Bronchoalveolar Lavage Fluid Testing for the Diagnosis of Cytomegalovirus Pneumonitis

Updated international consensus guidelines on the management of cytomegalovirus in solid-organ transplantation.

Recent advances in cytomegalovirus: an update on pharmacologic and cellular therapies.

Diagnostic yield of the cytomegalovirus (CMV) antigenemia assay and clinical features in solid organ transplant recipients and hematopoietic stem cell transplant recipients with CMV pneumonia.

Clinical course of cytomegalovirus (CMV) viremia with and without ganciclovir treatment in CMV-seropositive kidney transplant recipients. Longitudinal follow-up of CMV pp65 antigenemia assay.

Quantification of cytomegalovirus (CMV) viral load by the hybrid capture assay allows for early detection of CMV disease in lung transplant recipients.

Correlation between viral loads of cytomegalovirus in blood and bronchoalveolar lavage specimens from lung transplant recipients determined by histology and immunohistochemistry.

Comparison of high-resolution computed tomography findings between Pseudomonas aeruginosa pneumonia and Cytomegalovirus pneumonia.

Virologic suppression measured by a cytomegalovirus (CMV) DNA test calibrated to the World Health Organization international standard is predictive of CMV disease resolution in transplant recipients.

P31

scholarly article

P356

10.1111/CTR.13149

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Elena Beam

P577

2017-11-07T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29112278

http://www.w3.org/2001/XMLSchema#string

P921

bronchoalveolar lavage